4882.T
Price:
$292
Market Cap:
$4.31B
Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Industry
Drug Manufacturers - General
IPO Date
2021-06-22
Stock Exchange
JPX
Ticker
4882.T
According to Perseus Proteomics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.49. This represents a change of -43.82% compared to the average of -9.77 of the last 4 quarters.
The mean historical PE Ratio of Perseus Proteomics Inc. over the last ten years is -8.17. The current -5.49 PE Ratio has changed 6.62% with respect to the historical average. Over the past ten years (40 quarters), 4882.T's PE Ratio was at its highest in in the June 2023 quarter at -1.97. The PE Ratio was at its lowest in in the March 2025 quarter at -12.89.
Average
-8.17
Median
-7.42
Minimum
-14.67
Maximum
-3.45
Discovering the peaks and valleys of Perseus Proteomics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 236.69%
Maximum Annual PE Ratio = -3.45
Minimum Annual Increase = -47.94%
Minimum Annual PE Ratio = -14.67
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -11.61 | 236.69% |
| 2024 | -3.45 | -22.58% |
| 2023 | -4.45 | -41.69% |
| 2022 | -7.64 | -47.94% |
| 2021 | -14.67 | 103.53% |
The current PE Ratio of Perseus Proteomics Inc. (4882.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.50
5-year avg
-8.36
10-year avg
-8.17
Perseus Proteomics Inc.’s PE Ratio is less than Ribomic Inc. (-3.46), less than Carna Biosciences, Inc. (-2.15), less than Delta-Fly Pharma, Inc. (-3.35), less than D. Western Therapeutics Institute, Inc. (-4.32), greater than Cyfuse Biomedical K.K. (-5.80), less than Immuno-Biological Laboratories Co., Ltd. (50.23), greater than teno. Holdings Company Limited (-14.90), less than FunPep Company Limited (-2.48), less than Living Platform,Ltd. (11.74), less than Kubota Pharmaceutical Holdings Co., Ltd. (-2.61),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.46 | $3.64B | |
| -2.15 | $4.60B | |
| -3.35 | $5.91B | |
| -4.32 | $4.56B | |
| -5.80 | $5.15B | |
| 50.23 | $12.99B | |
| -14.90 | $4.11B | |
| -2.48 | $3.49B | |
| 11.74 | $4.78B | |
| -2.61 | $3.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Perseus Proteomics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Perseus Proteomics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Perseus Proteomics Inc.'s PE Ratio?
How is the PE Ratio calculated for Perseus Proteomics Inc. (4882.T)?
What is the highest PE Ratio for Perseus Proteomics Inc. (4882.T)?
What is the 3-year average PE Ratio for Perseus Proteomics Inc. (4882.T)?
What is the 5-year average PE Ratio for Perseus Proteomics Inc. (4882.T)?
How does the current PE Ratio for Perseus Proteomics Inc. (4882.T) compare to its historical average?